MPM Bio Consultancy. Translating biotechnology into clinical reality
Independent Consulting Sydney · Available Worldwide

Translating biotechnology into clinical reality.

Strategic and technical consulting in medical biotechnology, biosensors, and point-of-care diagnostics — for startups, research labs, and clinical innovators turning molecules into products.

§ 01 · Domains

Areas of expertise

01 / 06

Biosensor design

02 / 06

Point-of-care diagnostics

03 / 06

Nanobiotechnology

04 / 06

Bioreagent development for in vitro diagnostics
incl. protein & antibody engineering

05 / 06

Assay development

06 / 06

Translational R&D

§ 02 · Services

How I can help

S/01

Technology assessment

Independent technical due diligence on biotech platforms, IP portfolios, and product feasibility for investors and founders.

Diligence
S/02

R&D advisory

Hands-on guidance for early-stage labs developing biosensors, diagnostics, or nanobio products — from protocol design to data interpretation.

Advisory
S/03

Grant & manuscript review

Critical review of grant proposals, peer-reviewed manuscripts, and white papers in biosensors, diagnostics, and nanomedicine.

Editorial
S/04

Assay troubleshooting

Diagnose and resolve sensitivity, specificity, and reproducibility issues in immunoassays, lateral flow, and electrochemical platforms.

Technical
S/05

Strategic consulting

Long-term consulting partnerships for biotech startups: product roadmap, hiring, technical positioning, and investor narratives.

Strategy
S/06

Workshops & training

Custom workshops on nanobiosensor fundamentals, POC diagnostic design, and lab best practices for teams and academic groups.

Education
§ 03 · Profile

About Dr. Pourhassan-Moghaddam

Mohammad Pourhassan-Moghaddam is a biomedical scientist with more than a decade of research experience at the intersection of nanotechnology, biosensors, and clinical diagnostics. His work spans gold-nanoparticle bioconjugation, point-of-care immunoassay design, and silicon nanowire field-effect transistors for intraoperative cancer detection.

He has held research positions at the University of New South Wales and the University of Technology Sydney, with international collaborations. His publications have been cited over a thousand times across journals including ACS Nano, TrAC Trends in Analytical Chemistry, and Materials Science and Engineering: C.

He now offers selective consulting engagements to translate that experience into practical outcomes for biotech teams building the next generation of medical diagnostics.

Affiliation
University of New South Wales
Specialisation
Biodiagnostics · Point-of-Care · Bioreagents
Based in
Sydney, Australia
34+
Publications
1k+
Citations
12+
Years R&D
§ 04 · Engagement

Ways to work together

§ 05 · Get in touch

Let's build something that matters.

If you're working on biotechnology that could improve human health, I'd like to hear about it. Reach out with a short note about your project and what you're trying to solve.

Send an email Connect on LinkedIn